Oxis Intl Inc (OXIS) 0.0319 $OXIS Cannabis Stocks On The

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Oxis Intl Inc (OXIS) 0.0319 $OXIS

Cannabis Stocks On The Rise In 2015
ACCESSWIRE - Thu May 14, 10:10AM CDT
CORAL GABLES, FL / ACCESSWIRE / May 14, 2015 / Cannabis stocks have rallied in 2015 thus far. With more and more states jumping on board the marijuana legalization train, companies are now trying to take advantage of this rapidly growing space. For instance, companies that are biotech/cannabis focused companies like Oxis International (OTCQB: OXIS), security surveillance for dispensaries like Blue Line Protection Group (PINKSHEETS: BLPG), or hemp infused Beverage Companies like Totally Hemp Crazy Inc (PINKSHEETS: THCZ) have found their place in the MJ space in 2015.

OXIS Biotech Retains The Emmes Group To Assist With Its Strategic Business And Therapeutic Development Initiatives
PR Newswire - Tue May 12, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] announced today that it has retained the Emmes Group to assist with the development and execution of the Company's business, partnership, and technology licensing initiatives and strategies.

How High Have Cannabis Stocks Been This Year And Where Do You Stand?
ACCESSWIRE - Fri May 08, 11:10AM CDT
CORAL GABLES, FL / ACCESSWIRE / May 8, 2015 / Interest in cannabis companies has continued to grow in 2015 as more states have begun to implement legalization efforts; these including options for both medical and recreational use. After more states like Texas have put wheels in motion for legalization efforts, more attention has begun to build and the 2015 market for cannabis stocks has started to look much different than the uncertainty that was seen last year. Companies like Oxis International (OTCQB: OXIS), Pazoo, Inc. (PINKSHEETS: PZOO), and Totally Hemp Crazy Inc (PINKSHEETS: THCZ) have all seen record 6-month highs this year as a flood of positive news and a more informed investment community have bolstered movement within the market.

The "Tech" Behind Biotechnology Has Evolved; 2015 Marks New Milestones
ACCESSWIRE - Thu May 07, 10:01AM CDT
CORAL GABLES, FL / ACCESSWIRE / May 7, 2015 / The biotechnology industry has come a long way from where it was even 10 years ago. New findings, developments, and enacted regulations have given rise to programs only once dreamed of. Nearly half of America is behind the legalization of cannabis; many in favor of medical use and other novel therapies to treat the effects of cancer. Companies like Oxis International, Inc. (OTCQB: OXIS), PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), and PharmaCyte Biotech, Inc. (OTCQB: PMCB) have all begun the push for brining certain therapies to market.
PTBI: 7.98 (-0.36)

Will These Cannabis Stocks Be On Your Watchlist For May?
ACCESSWIRE - Tue May 05, 1:14PM CDT
CORAL GABLES, FL / ACCESSWIRE / May 5, 2015 / Marijuana stocks have made a serious comeback since the start of the New Year. With the hit taken by cannabis companies in 2014 it has attracted investors to invest in oversold cannabis plays. Now it's 2015 and with 23 states including the District of Columbia jumping on the marijuana legislation train, companies are finding new innovative ways to become part of the cannabis industry. For example, biotech/cannabis focused companies like Oxis International (OTCQB: OXIS), Hemp infused beverage wholesalers like Totally Hemp Crazy Inc. (PINKSHEETS: THCZ) and even extensive security & protection services like Blue Line Protection Group (PINKSHEETS: BLPG) have all found their niche in the industry.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part VIII
Anthony Cataldo - at Seeking Alpha - Mon Apr 20, 7:25AM CDT

QAI: 30.09 (+0.03)

How Will The Cannabis Industry Look In 2015?
ACCESSWIRE - Thu Apr 16, 7:53AM CDT
CORAL GABLES, FL / ACCESSWIRE / April 16, 2015 / Cannabis stocks are in turnaround. After new states recently legalized cannabis for recreational use and many other states for medicinal use. The bottom line is Cannabis is showing progress, and this could lead to more money to make as an investor. After seeing the numbers from last year both from a revenue standpoint and a tax generation focus, many more individuals, businesses, and investors are becoming more educated on the subject. There have even been new state and federal initiatives put in motion to further open the market throughout the US.

Oxis Biotech Inc. Announces Resumption of Trading of Common Stock on Euronext Paris
PR Newswire - Fri Apr 10, 6:30AM CDT
Oxis International, Inc. (OXIS) (OXI.PA), a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015. Upon resumption of trading, the shares will trade in a double call auction trading mode (fixing) rather than the continuous trading mode formerly applicable to Oxis shares.

Oxis Biotech Discusses Its Immunotherapeutic Development Strategy
PR Newswire - Wed Apr 01, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] discussed during its March 31, 2015 conference call with shareholders, analysts and other interested parties certain aspects of its immunotherapeutic development strategy. During the teleconference, Anthony J. Cataldo, Chairman and Chief Executive Officer stated that Oxis Biotech is focused on developing immunotherapies for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.

Oxis International Inc. Announces Request for Euronext Trading Suspension
PR Newswire - Tue Mar 31, 8:07AM CDT
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on biotech cancer therapy development and commercialization, announced today Oxis CEO Tony Cataldo has requested a suspension of the trading of Oxis common shares on the Euronext exchange. Oxis shares will continue to trade on the OTCQB under the symbol OXIS.

MarijuanaStocks.com to Host Oxis International (OXIS) Conference Call with CEO Tony Cataldo
ACCESSWIRE - Mon Mar 30, 11:38AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 30, 2015 / MarijuanaStocks.com-Oxis International (OTCQB: OXIS) recently announced that the Company will be holding an investor conference call on Tuesday, March 31, 2015 at 4:15pm EST to discuss recent corporate developments. As a result of receiving emails and social media messages from our loyal followers as to who will be hosting the conference call and how attendees can ask specific questions, MatrijuanaStocks.com reached out to OXIS CEO Tony Cataldo and expressed the amount of interest our followers have in the upcoming conference call.

Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh
PR Newswire - Thu Mar 26, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of an exclusive option agreement with the University of Pittsburgh related to certain patents/intellectual properties developed by Dr. Xiang-Qun Xie, Associate Dean for Research Innovation and Professor, Pharmaceutical Sciences, School of Pharmacy. These patents/intellectual properties relate to novel compositions-of-matter which could prove useful as therapeutics for the treatment of various human diseases. The term of the exclusive option is eighteen (18) months. During the term of exclusivity, the University of Pittsburgh will not offer third parties the opportunity to license these intellectual properties.

Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.

Rapidly Rising: Fastfunds Financial Corporation (OTCBB:FFFC)
ACCESSWIRE - Tue Mar 17, 11:55PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2015 / The Cannabis Capitalist, an Investment newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known stocks in the new recreational and medical Cannabis industry, would like to announce a new Company which is creating excitement on Wall Street: Fastfunds Financial (OTCBB:FFFC).
CARA: 9.99 (-0.14), GWPH: 112.25 (-0.07)

MultiCell inks R&D agreement with Oxis Biotech
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 12:10PM CDT


Oxis Biotech Licenses Rights To Antibody-Drug Conjugates For The Treatment Of Cancer
PR Newswire - Thu Mar 12, 6:30AM CDT
Oxis Biotech, Inc. (OXIS), a wholly owned subsidiary of Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: OXI.PA] announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. (MCIT) concerning the development of certain antibody-drug conjugates (ADCs). These ADCs are thought to be useful for the treatment of triple-negative breast cancer, and multiple myeloma and associated osteolytic lesions which are significant unmet medical needs.

Penny Stocks Trending Alerts for Eventure Interactive, Telupay International, TOTALLY HEMP CRAZY, OXIS International, Monster Arts, and BE ACTIVE HOLDINGS
PR Newswire - Mon Mar 09, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Eventure Interactive (OTCBB:EVTI), Telupay International (OTCMKTS:TLPY), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), OXIS International (OTCMKTS:OXIS), Monster Arts (OTCBB:APPZ), and BE ACTIVE HOLDINGS (OTCMKTS:JALA).

48 Marijuana Stocks - A Post-Mortem: Part II
Anthony Cataldo - at Seeking Alpha - Wed Mar 04, 7:36AM CST

INSY: 59.00 (+0.17), FULL: 3.52 (-0.01), CARA: 9.99 (-0.14)

Top 5 Cannabis Stocks to Watch in 2015
ACCESSWIRE - Wed Feb 11, 8:39AM CST
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It's been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth driven marketplace full of opportunity. It seems like those entering the space are facing the "kid in a candy store" mentality as so many industry assets can be applied to this new sector. From consulting services to biotech, there is a myriad of options for companies to focus on during these early stages. But the question remains, "Are 'pot' stocks really delivering for investors?" So, which stocks should you be in right now?

Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application
PR Newswire - Wed Feb 04, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, provided today an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 114

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 99

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Veterans United Foundation Marks 15 Years of Giving

Updated Category News Views 0

A Milestone Measured in More Than Checks Fifteen years can turn a workplace charity into background noise, but this one plainly has not drifted into autopilot. Veterans United Foundation closed its 2026 anniversary campaign, called The Good Goes On, with $1.5 million directed to charitable organizations, 1,145 employee volunteers, and 2,680 hours of hands-on work. That is...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 52

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 305

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 319

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 24

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
Racura's AML Trial Clears Its First Crucial Hurdle

Updated Category News Views 13

One signature from Sheba does not cure leukemia, but it does move Racura Oncology from talking about EMILI to doing the hard, expensive work of enrolling patients. For a company at this stage, that distinction matters. Ethics approval for the seamless Phase 2b/3 RC220 study in relapsed or refractory acute myeloid leukemia is a real operational milestone, not the sort of...

Continue Reading
SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 225

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading

Top 5 Most Recently Viewed Articles

AEA Private Debt's Strategic Investment in Weller Metalworks

Updated Category News Views 299

Let's cut to the chase: AEA Private Debt is making some serious waves in the middle market with its latest move as the Sole Provider of mezzanine notes for Weller Metalworks' acquisition of DROP Sprockets, Inc. This isn’t just another deal; it’s a calculated step in an increasingly competitive landscape where metal fabrication firms are vying for supremacy. Weller...

Continue Reading
Medication Management Partners Continues to Excel in Senior Care

Updated Category News Views 196

Medication Management Partners Earns Prestigious Recognition In recent news, Medication Management Partners (MMP), a leading long-term care pharmacy, proudly announces its place on the Inc. 5000 list of fastest-growing private companies in America for the seventh consecutive year. This achievement signifies the company’s steady growth and innovative practices in the...

Continue Reading
AlphaGen Unveils Major Expansion Plans for Power Generation

Updated Category News Views 501

AlphaGen's Ambitious 450 MW Power Generation Initiative Alpha Generation, LLC ("AlphaGen"), based in Stamford, Conn., is taking a significant step towards meeting the escalating demand for reliable electric power across the nation. With plans to add approximately 450 megawatts (MW) of additional electric generation at four existing power stations, AlphaGen aims to bolster...

Continue Reading
STAT Secures a Loeb Award for Outstanding Reporting on Opioids

Updated Category News Views 185

STAT Achieves Recognition for Vital Reporting STAT addiction reporter Lev Facher has been honored with a 2025 Loeb Award for his exceptional work in explanatory reporting. This award, regarded as the pinnacle of accomplishment in business and financial journalism, recognizes Facher's six-part series titled "The War on Recovery." The compelling series sheds light on the...

Continue Reading
Investigation into Nomura Holdings, Inc. Sparks Investor Concerns

Updated Category News Views 67

Introduction to the Investigation of Nomura Holdings, Inc. Pomerantz LLP is currently conducting an investigation focused on claims made on behalf of investors of Nomura Holdings, Inc. (NYSE: NMR). The essence of this investigation revolves around whether Nomura and some of its key officers or directors may have engaged in securities fraud or other illicit business...

Continue Reading